Business
Tilray’s CC Pharma Recognized as a TOP 100 Innovator in Germany
Award Recognizes CC Pharma as an Innovative Leader and Trusted Partner in the European Pharmaceutical MarketDENSBORN, Germany, Feb. 04, 2026 (GLOBE NEWSWIRE)
About this update from Tilray Brands, Inc.
[{"type":"text","content":"Award Recognizes CC Pharma as an Innovative Leader and Trusted Partner in the European Pharmaceutical MarketDENSBORN, Germany, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Tilray Pharma the pharmaceutical division of Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), today announced that CC Pharma, its European pharmaceutical distribution business, has been named a TOP 100 Innovator in Germany, one of the country’s most respected and independent recognitions for innovation among small and mid-sized enterprises. CC Pharma operates a nationwide pharmaceutical distribution network serving more than 13,000 pharmacies across Germany, providing reliable access to a broad portfolio of prescription and over-the-counter medicines. The company also plays a key role in the distribution of medical cannabis in Germany, leveraging its established infrastructure, regulatory expertise, and long-standing relationships within the healthcare system to support patient access in a highly regulated market. For more than 25 years, the TOP 100 Innovator Award has recognized companies demonstrating exceptional innovative strength, long-term viability, and future-focused business practices. Winners are selected through a rigorous, science-based evaluation that assesses innovation management, forward-looking strategy, and sustainable competitiveness, making the TOP 100 seal a trusted signal to customers, suppliers, financial institutions, media, and prospective employees. Rajnish Ohri, President, International, Tilray Brands, stated, “This recognition underscores CC Pharma’s role as a forward-thinking, reliable partner within Germany’s pharmaceutical ecosystem. Innovation is not just about technology, it’s about building resilient systems, anticipating market needs, and consistently delivering value to partners and patients. CC Pharma exemplifies this approach, and this award reinforces the strength of our European pharmaceutical platform.” Mathias Bossen, Managing Director of CC Pharma, stated, “We are proud to be recognized as a TOP 100 Innovator in Germany. This award validates the work of our entire team and our focus on continuous improvement, digitalization, and long-term partnerships. It confirms that CC Pharma is well positioned for the future and remains a trusted, innovative partner for customers, suppliers, and stakeholders across the pharmaceutical value cha...